Servicios Personalizados
Revista
Articulo
Español (pdf)
Articulo en XML
Referencias del artículo
Traducción automática
Enviar articulo por emailIndicadores
Citado por SciELO
Links relacionados
Similares en
SciELO
Compartir
Permalink
Revista de Neuro-Psiquiatría
versión impresa ISSN 0034-8597
Resumen
CRUZADO, Lizardo y HURTADO-LLAMO, Nuria Diana. Apparent rapid response to the combination of zolpidem, memantine and aripiprazole in a case of schizophrenic catatonia. Rev Neuropsiquiatr [online]. 2023, vol.86, n.3, pp.245-250. Epub 03-Nov-2023. ISSN 0034-8597. http://dx.doi.org/10.20453/rnp.v86i3-1.4980.
Objective:
The treatment of catatonia usually involves the use of benzodiazepines and, if these fail, electroconvulsive therapy is applied. Nevertheless, hypothetical neurobiological pathways involved in catatonia postulate beneficial effects of GABAergic drugs and glutamate blockers.
Clinical case:
A 45-year-old female patient, diagnosed with paranoid schizophrenia who developed a catatonic stupor (with no response to benzodiazepines) and various medical complications; however, the condition improved rapidly with the combination of zolpidem, memantine and aripiprazole.
Result:
A favorable outcome was obtained in this case, not achieved with the previous use of standard benzodiazepine therapy.
Conclusions:
The combination of GABAergic drugs and glutamate blockers can be beneficially implemented in cases of catatonic stupor that fail to respond to the usual management with benzodiazepines.
Palabras clave : catatonia; stupor; GABA-A receptors.
